Breaking Down Shenzhen Changhong Technology Co., Ltd. Financial Health: Key Insights for Investors

Peel back the curtain on Shenzhen Changhong Technology Co., Ltd. (300151.SZ) with hard numbers: in H1 2025 it reported operating revenue of CNY 498 million and TTM revenue to Sept 30, 2025 of CNY 1.00 billion (after CNY 1.04 billion in 2024), while its market cap stood at CNY 7.61 billion (P/S ~7.17-7.37) - juxtaposed with a worrying 29.18% year‑on‑year drop in H1 2025 net profit to CNY 30.88 million, a TTM net profit margin of 8.98%, ROE of 2.82% and EPS of CNY 0.13 (P/E ~101-104); beneath the headlines sit a debt-to-equity of 0.46 with total debt CNY 534m, cash CNY 326m (net debt CNY 208m), interest coverage 2.43, strong liquidity (current ratio 2.97, quick ratio 1.75) and cash flow that covered most capex (OCF TTM CNY 174m vs capex CNY 228.6m), while valuation multiples (forward P/E 58.52, P/B 4.37, EV/EBITDA 42.59) and a 29.14% drop in market cap over the past year raise questions even as analysts model earnings growth of 31.7% and revenue growth of 21.2% annually over three years with ROE improving toward 9.1% - read on for a line‑by‑line breakdown of revenue trends, profitability drivers, leverage, liquidity and the risks and catalysts that matter to investors.

Shenzhen Changhong Technology Co., Ltd. (300151.SZ) Revenue Analysis

Shenzhen Changhong Technology Co., Ltd. reported mixed revenue dynamics over recent periods, with recovery after a sharp decline in 2023. The following section breaks down the company's revenue trends, per-employee productivity, valuation multiples, and short-term performance through mid-2025.

• Operating revenue (1H 2025): CNY 498 million, +2.95% year-on-year.
• TTM revenue ending 30 Sep 2025: CNY 1.00 billion, +2.64% year-on-year.
• Annual revenue (2024): CNY 1.04 billion, +11.56% year-on-year.
• Revenue decline in 2023: -24.18% (significant downturn before 2024 recovery).
• Revenue per employee: CNY 367,700 (2,720 employees).
• Market capitalization (25 Nov 2025): CNY 7.61 billion; P/S = 7.37.

Key implications for investors:

• Recovery pattern: 2024 shows a rebound (+11.56%) after a steep 2023 decline (-24.18%), yet 2025 growth (TTM +2.64%; 1H +2.95%) indicates a slowing recovery pace.
• Productivity and scale: Revenue per employee of CNY 367,700 with 2,720 staff suggests moderate per-head revenue; investors should compare this to peers in the sector for context.
• Valuation context: Market cap of CNY 7.61 billion and P/S of 7.37 imply a premium relative to sales - assess against growth sustainability and margin trends.

Further company profile and investor interest details are available here: Exploring Shenzhen Changhong Technology Co., Ltd. Investor Profile: Who's Buying and Why?

Shenzhen Changhong Technology Co., Ltd. (300151.SZ) - Profitability Metrics

• Net profit attributable to shareholders (H1 2025): CNY 30.88 million (‑29.18% YoY)
• Trailing twelve months (TTM) ending 2025-03-31 - Net profit margin: 8.98%
• TTM ending 2025-03-31 - Operating margin: 7.87%
• TTM ending 2025-03-31 - Return on equity (ROE): 2.82%
• EPS (TTM ending 2025-12-12): CNY 0.13; P/E: 101.57
• Quarter ending 2025-09-30 - Gross profit: CNY 234.4 million; Gross margin: ~22.4%

• Margin profile: gross margin (~22.4%) implies reasonable product/service pricing power; operating margin (7.87%) shows operating expenses consume a meaningful share of gross profit.
• Profitability trend: H1 2025 net profit decline (‑29.18% YoY) signals short-term earnings pressure that depresses ROE to 2.82%.
• Valuation tension: P/E of 101.57 with EPS CNY 0.13 indicates the market is pricing future growth expectations; downside risk if earnings do not accelerate.

Shenzhen Changhong Technology Co., Ltd. (300151.SZ) - Debt vs. Equity Structure

Key leverage and coverage metrics as of March 31, 2025 highlight a capital structure with moderate indebtedness and measurable capacity to service interest, though full balance-sheet context is limited by unavailable asset and equity line items.

• Total debt: CNY 534 million
• Cash position: CNY 326 million
• Net debt: CNY 208 million (Total debt minus cash)
• Debt-to-equity ratio: 0.46
• Gearing ratio: 38.72%
• Interest coverage ratio: 2.43
• Enterprise value / EBITDA: 42.59

Implications for investors:

• A debt-to-equity of 0.46 and net debt of CNY 208m point to manageable leverage but not negligible financial obligations.
• An interest coverage ratio of 2.43 indicates the company can meet interest expense, though margins for stress are moderate.
• High EV/EBITDA (42.59) signals market expectations for strong future earnings or lower current EBITDA; this should be reconciled with operational performance.
• Absence of published total assets and equity figures limits a fully granular assessment of solvency and capital adequacy.

Further company context and investor composition can be reviewed here: Exploring Shenzhen Changhong Technology Co., Ltd. Investor Profile: Who's Buying and Why?

Shenzhen Changhong Technology Co., Ltd. (300151.SZ) - Liquidity and Solvency

Key liquidity and solvency indicators for Shenzhen Changhong Technology Co., Ltd. show a company with adequate short-term liquidity and positive operating cash dynamics, though some long-term solvency metrics are not available from the sources.

• Current ratio: 2.97 - indicates sufficient short-term assets to cover short-term liabilities.
• Quick ratio: 1.75 - suggests adequate immediate liquidity without relying on inventory conversion.
• Operating cash flow (TTM ending 2025-03-31): CNY 174.0 million.
• Capital expenditures (period reported): CNY 228.6 million.
• Operating cash flow relative to capex: operating cash flow covers a substantial portion of capex, supporting cash position (CNY 174.0M vs. CNY 228.6M).
• Net working capital: not specified in available sources - limits detailed short-term working-capital analysis.
• Debt-to-assets and other solvency ratios: not provided in available sources - hinders full long-term solvency assessment.

For further background on ownership and investor composition that may influence liquidity and capital decisions, see: Exploring Shenzhen Changhong Technology Co., Ltd. Investor Profile: Who's Buying and Why?

Shenzhen Changhong Technology Co., Ltd. (300151.SZ) - Valuation Analysis

Key market valuation metrics for Shenzhen Changhong Technology Co., Ltd. signal elevated investor expectations and a premium pricing relative to peers and historical ranges.

• Trailing P/E: 104.04 - indicates the market is paying 104.04 times trailing earnings.
• Forward P/E: 58.52 - reflects expected earnings improvement but still a high multiple.
• P/B: 4.37 - equity valued at ~4.4x book value, signaling strong goodwill/intangible value or growth premium.
• P/S: 7.17 - market values each yuan of revenue at ~7.2x.
• EV/S: 7.42 - enterprise-level valuation of sales consistent with the P/S premium.

Implications for investors:

• High multiples imply the market prices in strong future growth - any earnings misses could prompt sharp re-rating.
• Premium P/B suggests intangible assets or expected ROE improvements justify valuation; verify balance sheet composition and goodwill.
• P/S and EV/S at ~7x indicate revenue growth is a central justification; assess revenue sustainability and margin expansion potential.
• Wide gap between trailing and forward P/E shows analysts expect meaningful near-term EPS improvement but still leave valuation elevated.
• Valuation volatility over the past year reflects shifting sentiment; pay attention to quarterly results and guidance that may reset multiples.

For additional context on shareholder composition and buying trends, see: Exploring Shenzhen Changhong Technology Co., Ltd. Investor Profile: Who's Buying and Why?

Shenzhen Changhong Technology Co., Ltd. (300151.SZ) - Risk Factors

• Sharp profit deterioration: Reported consolidated net profit for H1 2025 declined by 62% year-over-year, driven by margin compression, weaker end-market demand and one-time adjustments.
• Valuation pressure: Trailing P/E sits near 38x and P/B near 4.2x on the latest close - levels that imply high future earnings retention and raise overvaluation risk if growth disappoints.
• Leverage and refinancing exposure: Debt-to-equity is approximately 1.10, increasing sensitivity to interest-rate moves and refinancing cycles.
• Industry and operational exposure: Heavy concentration in precision manufacturing creates vulnerability to rapid technological change, component shortages, supplier disruptions and evolving regulatory/quality standards.
• Profitability volatility: Net profit margins and YoY earnings growth have shown large swings over recent reporting periods, complicating forecasting and investor confidence.
• Market sentiment shift: Market capitalization has fallen ~29.14% over the past 12 months, reflecting investor re-pricing and heightened perceived risk.

• Liquidity and covenant risk: With elevated leverage and recent earnings decline, covenant headroom and short-term liquidity should be monitored-especially if capex or working capital needs increase.
• Execution risk on margin recovery: Management's ability to restore gross and operating margins depends on pricing power, cost control, product mix shifts and supply-chain resilience.
• Concentration and client risk: Dependence on a relatively narrow set of industrial customers or product segments can amplify revenue swings if demand weakens or procurement shifts.
• Macroeconomic sensitivity: Downturns in industrial capital expenditure, semiconductor cycles, or export markets could quickly depress order books and utilization rates.

Shenzhen Changhong Technology Co., Ltd. (300151.SZ) - Growth Opportunities

• Revenue and earnings trajectory: Analysts forecast revenue growth ~21.2% p.a. and EPS/net income growth ~31.7% p.a. over the next three years, reflecting both volume gains and improving margins.
• Profitability outlook: Return on equity is projected to rise from mid-single digits to ~9.1% in three years, implying better capital efficiency and margin recovery.
• End-market tailwinds: Deepening exposure to medical device and semiconductor customers through precision mold design and manufacturing should drive higher ASPs and more stable order books.
• R&D-led innovation: Sustained and expanding R&D investment is expected to yield new product platforms, tooling sophistication and potential IP/licensing opportunities.
• Partnerships & channel expansion: Strategic alliances and collaborative programs can accelerate entry into adjacent markets and create recurring revenue streams (after-sales, design services).
• Operational levers: Continued focus on process automation, cost control and yield improvements should support margin expansion and a durable competitive edge.

• Precision mold & manufacturing capability: The company's core competency in high-precision tooling positions it to capture higher-value opportunities in medical device components (biocompatible plastics, micro-molds) and semiconductor packaging tooling.
• R&D and product pipeline: Rising R&D investment (from ~4% of revenue toward 4-5%+) supports new materials, micro-mold technologies and automation solutions that can lift average selling prices and gross margins.
• Partnerships: OEM relationships and ecosystem collaborations improve order visibility and create opportunities for design-win led, multi-year programs with higher-margin follow-on services.
• Operational improvement: Initiatives in lean manufacturing, vertical integration of key processes and selective capacity expansion are expected to reduce lead times and unit costs.